---
figid: PMC5570578__gr7
figlink: /pmc/articles/PMC5570578/figure/f0035/
number: Figure 7
caption: Illustration describing the role of HPV E6/E7 oncogenes and HPV E6/E7 siRNA
  with cisplatin (CDDP) plus paclitaxel (PTX) therapy on HPV-infected cervical cancer
  cell fates. HPV-E6 and E7 bind to TP53 and RB (tumor suppressors proteins) and degrade
  the protein, respectively, leading to repression of p21 (p21WAF1/Cip1) and facilitating
  free E2Fs through the activation of cyclin/CDK complexes. As a result of triple
  combination therapy, inactivation of TP53 and RB/E2F pathway is prevented, and TP53,
  p21, and hypophosphorylated RB (pRB) protein level increases. Overall, high level
  of TP53 results in cell cycle arrest and cell proliferation inhibition. Arrows indicate
  a positive effect, while flat lines indicate inhibition.
pmcid: PMC5570578
papertitle: Effect of HPV E6/E7 siRNA with Chemotherapeutic Agents on the Regulation
  of TP53/E2F Dynamic Behavior for Cell Fate Decisions.
reftext: Nirmal Rajasekaran, et al. Neoplasia. 2017 Oct;19(10):735-749.
pmc_ranked_result_index: '40327'
pathway_score: 0.9272068
filename: gr7.jpg
figtitle: Illustration describing the role of HPV E6/E7 oncogenes and HPV E6/E7 siRNA
  with cisplatin (CDDP) plus paclitaxel (PTX) therapy on HPV-infected cervical cancer
  cell fates
year: '2017'
organisms: Homo sapiens
ndex: 5eeeeed4-df0c-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5570578__gr7.html
  '@type': Dataset
  description: Illustration describing the role of HPV E6/E7 oncogenes and HPV E6/E7
    siRNA with cisplatin (CDDP) plus paclitaxel (PTX) therapy on HPV-infected cervical
    cancer cell fates. HPV-E6 and E7 bind to TP53 and RB (tumor suppressors proteins)
    and degrade the protein, respectively, leading to repression of p21 (p21WAF1/Cip1)
    and facilitating free E2Fs through the activation of cyclin/CDK complexes. As
    a result of triple combination therapy, inactivation of TP53 and RB/E2F pathway
    is prevented, and TP53, p21, and hypophosphorylated RB (pRB) protein level increases.
    Overall, high level of TP53 results in cell cycle arrest and cell proliferation
    inhibition. Arrows indicate a positive effect, while flat lines indicate inhibition.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ATM
  - E2F5
  - CHEK2
  - TP53
  - E2F8
  - E2F1
  - E2F6
  - E2F3
  - E2F4
  - ATR
  - CDK2
  - E2F2
  - CCNE1
  - E2F7
  - CCNE2
  - CHEK1
  - Cisplatin
  - Paclitaxel
genes:
- word: ATM
  symbol: ATM
  source: hgnc_symbol
  hgnc_symbol: ATM
  entrez: '472'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F5
  entrez: '1875'
- word: CHK2
  symbol: CHK2
  source: hgnc_alias_symbol
  hgnc_symbol: CHEK2
  entrez: '11200'
- word: TP53
  symbol: TP53
  source: hgnc_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F8
  entrez: '79733'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F1
  entrez: '1869'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F6
  entrez: '1876'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F3
  entrez: '1871'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F4
  entrez: '1874'
- word: ATR
  symbol: ATR
  source: hgnc_symbol
  hgnc_symbol: ATR
  entrez: '545'
- word: CDK2
  symbol: CDK2
  source: hgnc_symbol
  hgnc_symbol: CDK2
  entrez: '1017'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F2
  entrez: '1870'
- word: Cyclin-E
  symbol: Cyclin_E
  source: bioentities_symbol
  hgnc_symbol: CCNE1
  entrez: '898'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F7
  entrez: '144455'
- word: Cyclin-E
  symbol: Cyclin_E
  source: bioentities_symbol
  hgnc_symbol: CCNE2
  entrez: '9134'
- word: CHK1
  symbol: CHK1
  source: hgnc_alias_symbol
  hgnc_symbol: CHEK1
  entrez: '1111'
chemicals:
- word: Cisplatin
  source: MESH
  identifier: D002945
- word: Paclitaxel
  source: MESH
  identifier: D017239
diseases: []
---
